British Columbia Investment Management’s United Therapeutics UTHR Stock Holding History

British Columbia Investment Management’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.34M	Sell	5,638 -1,953	-26%	-$973K	0.02%	464
2025 Q4	$3.7M	Buy	7,591 +1,432	+23%	+$667K	0.02%	483
2025 Q3	$2.58M	Sell	6,159 -555	-8%	-$187K	0.01%	527
2025 Q2	$1.93M	Sell	6,714 -1,397	-17%	-$418K	0.01%	590
2025 Q1	$2.5M	Buy	8,111 +16	+0.2%	+$5.48K	0.02%	574
2024 Q4	$2.86M	Buy	8,095 +1,061	+15%	+$390K	0.02%	559
2024 Q3	$2.52M	Sell	7,034 -1,531	-18%	-$517K	0.02%	565
2024 Q2	$2.73M	Buy	8,565 +2,955	+53%	+$782K	0.02%	539
2024 Q1	$1.29M	Buy	5,610 +207	+4%	+$46.7K	0.01%	672
2023 Q4	$1.19M	Buy	5,403 +1,140	+27%	+$263K	0.01%	669
2023 Q3	$963K	Buy	4,263 +91	+2%	+$21K	0.01%	650
2023 Q2	$921K	Buy	4,172 +115	+3%	+$25.5K	0.01%	670
2023 Q1	$909K	Buy	+4,057	New	+$1M	0.01%	670
2019 Q2	–	Sell	-9,749	Closed	-$1.14M	–	794
2019 Q1	$1.14M	Sell	9,749 -1,225	-11%	-$143K	0.01%	735
2018 Q4	$1.2M	Sell	10,974 -35,784	-77%	-$4.15M	0.01%	721
2018 Q3	$5.98M	Buy	46,758 +16,019	+52%	+$1.98M	0.06%	355
2018 Q2	$3.48M	Buy	30,739 +11,591	+61%	+$1.27M	0.03%	546
2018 Q1	$2.15M	Buy	19,148 +13,181	+221%	+$1.67M	0.02%	646
2017 Q4	$883K	Buy	5,967 +2,974	+99%	+$378K	0.01%	679
2017 Q3	$351K	Hold	2,993	–	–	﹤0.01%	691
2017 Q2	$388K	Sell	2,993 -9,142	-75%	-$1.14M	﹤0.01%	691
2017 Q1	$1.64M	Sell	12,135 -7,516	-38%	-$1.14M	0.01%	636
2016 Q4	$2.82M	Sell	19,651 -6,325	-24%	-$808K	0.02%	585
2016 Q3	$3.07M	Sell	25,976 -7,393	-22%	-$888K	0.03%	546
2016 Q2	$3.53M	Buy	33,369 +154	+0.5%	+$17.2K	0.03%	533
2016 Q1	$3.7M	Sell	33,215 -1,935	-6%	-$245K	0.03%	521
2015 Q4	$5.5M	Buy	35,150 +28,359	+418%	+$4.13M	0.05%	408
2015 Q3	$891K	Sell	6,791 -1,961	-22%	-$315K	0.01%	644
2015 Q2	$1.52M	Buy	+8,752	New	+$1.57M	0.01%	625

Other funds holding UTHR

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

British Columbia Investment Management's UTHR Position: Q1 2026 in Review

British Columbia Investment Management reduced its United Therapeutics (UTHR) stake by 26% in Q1 2026, selling an estimated $973K and leaving 5,638 shares worth $3.34M. The position accounts for 0.02% of the portfolio, ranked #464.

British Columbia Investment Management first reported a position in UTHR in Q2 2015 and has held it in 29 quarters since. The position peaked at $5.98M in Q3 2018. 851 funds tracked by Wall St. Rank hold UTHR as of Q1 2026.

British Columbia Investment Management held 5,638 shares of United Therapeutics worth $3.34M as of Q1 2026.
British Columbia Investment Management sold 1,953 United Therapeutics shares in Q1 2026, an estimated $973K.
United Therapeutics made up 0.02% of British Columbia Investment Management's portfolio in Q1 2026, its #464 holding.
British Columbia Investment Management first reported a position in United Therapeutics in Q2 2015 and has held it in 29 quarters since.
British Columbia Investment Management's United Therapeutics position peaked at $5.98M in Q3 2018.
851 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2026.

Based on British Columbia Investment Management's 13F filing for Q1 2026, filed 14 May 2026.